Science
-
With no approved treatments and little support, people with Long COVID turn to online drug markets
With no approved treatments, lack of support, and stigma against the disease, many people with Long COVID are using overseas pharmacies to source medications. Some of these treatments are widely used for other conditions, such as HIV and hepatitis C, but are not approved for use in Long COVID.
-
Research updates, December 10
-
Research updates, December 3
-
Research updates, November 26
-
RECOVER-TLC is moving toward new clinical trials, initiative leaders share in webinar
In a webinar on Thursday, leaders from the National Institute of Allergy and Infectious Diseases (NIAID) and Foundation for the National Institutes of Health (FNIH) shared updates from RECOVER-Treating Long COVID (RECOVER-TLC), an initiative that will launch new clinical trials to study Long COVID. Speakers discussed early results from an online portal in which Long…
-
Why are there almost no clinical trials for kids with Long COVID?
Experts who spoke with The Sick Times brought up many different reasons why developing new drugs for children with Long COVID has moved at such a glacial pace. Many pharmaceutical companies might not see Long COVID as profitable. And running trials in children is complex and expensive, as they can have different symptoms and underlying…
-
Research updates, November 19
-
Research updates, November 12
-
Live blog: Following the Fall 2024 PolyBio Symposium on Long COVID research
On Friday, a number of prominent Long COVID scientists are set to present updates on their work at the PolyBio Research Foundation’s fall research symposium. PolyBio is a leading organization in supporting formative Long COVID science; it has backed research into Long COVID’s biological causes as well as clinical trials aiming to address those underlying…
-
Research updates, November 5
*Editor’s note: The PolyBio Research Foundation, like The Sick Times, has received support from the Balvi and Kanro funds. Our newsroom operates independently of financial supporters.
Follow Us
get the latest long covid news
Trending
Recent ARTICLES
-
Trans people with Long COVID navigate a new “dark age” in trans health
-
National COVID-19 trends, October 13
-
Research updates, October 13
-
How I built a COVID-safer school that’s become the heart of a more caring community
-
Biological pathways and mechanistic trials centered at new Long COVID conference in Amsterdam
Tags
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance